Skip to main content

Costs for heart failure with normal vs reduced ejection fraction.

Publication ,  Journal Article
Liao, L; Jollis, JG; Anstrom, KJ; Whellan, DJ; Kitzman, DW; Aurigemma, GP; Mark, DB; Schulman, KA; Gottdiener, JS
Published in: Arch Intern Med
January 9, 2006

BACKGROUND: Among the elderly population, heart failure (HF) with normal ejection fraction (EF) is more common than classic HF with low EF. However, there are few data regarding the costs of HF with normal EF. In a prospective, population-based cohort of elderly participants, we compared the costs and resource use of patients with HF and normal and reduced EF. METHODS: A total of 4549 participants (84.5% white; 40.6% male) in the National Heart, Lung, and Blood Institute Cardiovascular Health Study were linked to Medicare claims from 1992 through 1998. By protocol echo examinations or clinical EF assessments, 881 participants with HF were characterized as having abnormal or normal EF. We applied semiparametric estimators to calculate mean costs per subject for a 5-year period. RESULTS: There were 495 HF participants with normal EF (186 prevalent at study entry and 309 incident during the study period) and 386 participants with abnormal EF (166 prevalent and 220 incident). Participants with abnormal EF had more cardiology encounters and cardiac procedures. However, compared with abnormal EF participants, the 5-year costs for normal EF participants were similar in both the prevalent ($33,023 with abnormal EF and $32,580 with normal EF; P=.93) and incident ($49,128 with abnormal EF and $45,604 with normal EF; P=.55) groups. In models accounting for comorbid conditions, the costs with normal and abnormal EF remained similar. CONCLUSIONS: Over a 5-year period, patients with HF and normal EF consume as many health care resources as those with reduced EF. These data highlight the substantial financial burden of HF with normal EF among the elderly population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Arch Intern Med

DOI

ISSN

0003-9926

Publication Date

January 9, 2006

Volume

166

Issue

1

Start / End Page

112 / 118

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • United States
  • Systole
  • Stroke Volume
  • Statistics, Nonparametric
  • Regression Analysis
  • Prospective Studies
  • Prevalence
  • Medicare
  • Incidence
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liao, L., Jollis, J. G., Anstrom, K. J., Whellan, D. J., Kitzman, D. W., Aurigemma, G. P., … Gottdiener, J. S. (2006). Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med, 166(1), 112–118. https://doi.org/10.1001/archinte.166.1.112
Liao, Lawrence, James G. Jollis, Kevin J. Anstrom, David J. Whellan, Dalane W. Kitzman, Gerard P. Aurigemma, Daniel B. Mark, Kevin A. Schulman, and John S. Gottdiener. “Costs for heart failure with normal vs reduced ejection fraction.Arch Intern Med 166, no. 1 (January 9, 2006): 112–18. https://doi.org/10.1001/archinte.166.1.112.
Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, et al. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med. 2006 Jan 9;166(1):112–8.
Liao, Lawrence, et al. “Costs for heart failure with normal vs reduced ejection fraction.Arch Intern Med, vol. 166, no. 1, Jan. 2006, pp. 112–18. Pubmed, doi:10.1001/archinte.166.1.112.
Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Gottdiener JS. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med. 2006 Jan 9;166(1):112–118.

Published In

Arch Intern Med

DOI

ISSN

0003-9926

Publication Date

January 9, 2006

Volume

166

Issue

1

Start / End Page

112 / 118

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • United States
  • Systole
  • Stroke Volume
  • Statistics, Nonparametric
  • Regression Analysis
  • Prospective Studies
  • Prevalence
  • Medicare
  • Incidence